Molecular biology of gynecological cancer (Review)

被引:17
作者
Sonoda, Kenzo [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka, Fukuoka 8128582, Japan
基金
日本学术振兴会;
关键词
gynecological cancer; molecular biology; oncogenesis; angiogenesis; targeted therapy; SISO CELLS RCAS1; OVARIAN-CANCER; BRCA2; MUTATIONS; E-CADHERIN; ADENOMATOUS POLYPOSIS; PERSONALIZED MEDICINE; HUMAN-PAPILLOMAVIRUS; TUMOR HETEROGENEITY; FAMILY-HISTORY; SEROUS OVARIAN;
D O I
10.3892/ol.2015.3862
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is a pathological condition in which the balance between cell growth and death is disordered. Various molecules have been reported to be involved in the oncogenic process of invasion, metastasis and resistance to treatment. An exponential growth in the collection of genomic and proteomic data in the past 20 years has provided major advances in understanding the molecular mechanisms of human cancer, which has been applied to diagnostic and treatment strategies. Targeted therapies have been developed and adopted, particularly for advanced, refractory or recurrent cancers, depending on individual molecular profiles. The aim of the present review is to provide a report of the current literature regarding the molecular biology of gynecological cancers.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 134 条
  • [41] TP53: a key gene in human cancer
    Guimaraes, DP
    Hainaut, P
    [J]. BIOCHIMIE, 2002, 84 (01) : 83 - 93
  • [42] Halperin R, 2001, EUR J GYNAECOL ONCOL, V22, P122
  • [43] Hallmarks of Cancer: The Next Generation
    Hanahan, Douglas
    Weinberg, Robert A.
    [J]. CELL, 2011, 144 (05) : 646 - 674
  • [44] The p53 pathway: positive and negative feedback loops
    Harris, SL
    Levine, AJ
    [J]. ONCOGENE, 2005, 24 (17) : 2899 - 2908
  • [45] Molecular and pathologic aspects of endometrial carcinogenesis
    Hecht, Jonathan L.
    Mutter, George L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4783 - 4791
  • [46] An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases
    Heng, Boon Chin
    Aubel, Dominique
    Fussenegger, Martin
    [J]. BIOTECHNOLOGY ADVANCES, 2013, 31 (08) : 1676 - 1694
  • [47] Targeting caspases in cancer therapeutics
    Hensley, Patrick
    Mishra, Murli
    Kyprianou, Natasha
    [J]. BIOLOGICAL CHEMISTRY, 2013, 394 (07) : 831 - 843
  • [48] SILENCING OF THE VHL TUMOR-SUPPRESSOR GENE BY DNA METHYLATION IN RENAL-CARCINOMA
    HERMAN, JG
    LATIF, F
    WENG, YK
    LERMAN, MI
    ZBAR, B
    LIU, S
    SAMID, D
    DUAN, DSR
    GNARRA, JR
    LINEHAN, WM
    BAYLIN, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) : 9700 - 9704
  • [49] Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors
    Ho, CL
    Karman, RJ
    Dehari, R
    Wang, TL
    Shih, LM
    [J]. CANCER RESEARCH, 2004, 64 (19) : 6915 - 6918
  • [50] MOLECULAR ORIGINS OF CANCER DNA Damage, Aging, and Cancer
    Hoeijmakers, Jan H. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (15) : 1475 - 1485